Clinical Trials Directory

Trials / Terminated

TerminatedNCT01236508

Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Ottawa Heart Institute Research Corporation · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that inflammation in carotid plaque is predictive of the extent of ischemic lesion burden on the brain and will add to risk stratification for individuals with carotid disease.

Detailed description

Objectives: 1. To investigate the relationship of carotid inflammation, as measured by FDG positron emission tomography (PET) to standardized uptake value in atherosclerotic plaque, with the number of covert brain infarcts. 2. To investigate the relationship of FDG PET standardized uptake value with the relative volume of white matter hyperintensity. 3. To correlate vascular inflammation in the entire aorta and aortoiliac vessels to carotid inflammation and cerebral infarcts and white matter disease.

Conditions

Interventions

TypeNameDescription
RADIATIONPET/CT imaging with F-18 fluorodeoxyglucoseDose of 5 MBq/kg F-18-FDG given to fasting participant. Nuclear whole body imaging starting at 3 hours post-injection. The relation of the PET/CT image results and both the number of covert brain infarcts and the extent of white matter MRI hyperintensity will be investigated.

Timeline

Start date
2010-11-01
Primary completion
2016-10-27
Completion
2016-10-27
First posted
2010-11-08
Last updated
2017-04-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01236508. Inclusion in this directory is not an endorsement.